跳到主要內容

Gibson Christopher 的 Form 4 申報

Recursion Pharmaceuticals, Inc.(RXRX),2022/4/20 申報

申報編號
0001209191-22-025124
申報時間
2022/4/20
交易日
2022/4/18
申報延遲
2 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 10 筆非衍生性交易、5 筆衍生性交易。公開市場賣出合計 $26.2 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Gibson ChristopherCIK 0001856369董事、高階主管(執行長)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2022/4/18Class A Common StockM行使選擇權取得+44,010$2.48+$109,144.8412,127直接
2022/4/18Class A Common StockS賣出處分−17,336$6.99F2−$121,178.64394,791直接
2022/4/18Class A Common StockC轉換取得+18,500$0.00F4$0413,291直接
2022/4/18Class A Common StockS賣出處分−18,500$6.70F5−$123,950394,791直接
2022/4/18Class A Common StockC轉換取得+500$0.00F4$0500間接
2022/4/18Class A Common StockS賣出處分−500$6.72F6−$3,3600間接
2022/4/18Class A Common StockC轉換取得+1,000$0.00F4$01,000間接
2022/4/18Class A Common StockS賣出處分−1,000$6.71F7−$6,7100間接
2022/4/18Class A Common StockC轉換取得+1,000$0.00F4$01,000間接
2022/4/18Class A Common StockS賣出處分−1,000$6.71F8−$6,7100間接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2022/4/18Class A Common StockC轉換處分−6,929,834$0.00F4$06,929,834直接
2022/4/18Class A Common StockM行使選擇權處分−1,207,294$0.00$01,207,294直接
2022/4/18Class A Common StockC轉換處分−547,000$0.00F4$0547,000間接
2022/4/18Class A Common StockC轉換處分−544,000$0.00F4$0544,000間接
2022/4/18Class A Common StockC轉換處分−140,875$0.00F4$0140,875間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

This transaction was executed in multiple trades at prices ranging from $6.98 to $7.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

F4

Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

表 I 有 4 筆、表 II 有 4 筆交易的價格引用這則附註。

F5

This transaction was executed in multiple trades at prices ranging from $6.46 to $7.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

F6

This transaction was executed in multiple trades at prices ranging from $6.46 to $7.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

F7

This transaction was executed in multiple trades at prices ranging from $6.47 to $7.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

F8

This transaction was executed in multiple trades at prices ranging from $6.46 to $7.00. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)